What Is The Growth Rate Of Global Single-Use Bioprocessing Market By 2028?

Single-use Bioprocessing Industry Overview

The global single-use bioprocessing market size was valued at USD 15.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 16.0% from 2021 to 2028. Advantages offered by Single-Use Technology (SUT), such as significant reduction in capital cost and facility construction time, have proliferated the use of disposables in the bioprocessing industry. This has resulted in the double-digit growth of the market for single-use bioprocessing.

Besides, despite the global economic loss due to the outbreak of the COVID-19 pandemic, the market experienced significant growth. Several CMOs and biomanufacturer have shifted their business focus to the production of therapeutics against SARS-CoV-2 infection using disposable technologies. in September 2020, Serum Institute selected ABEC’s Custom Single Run (CSR) technology to accelerate large-scale, single-use manufacturing of nearly 1.0 billion doses of Novavax vaccine which is designed against COVID-19.

Single-use Systems (SUS) are considered as a commercially viable approach to achieve maximum process efficiency and productivity by several end-users. As a result, SUS equipment is highly employed across the biomanufacturing phases, particularly in pre-commercial biopharmaceutical manufacturing. This has created opportunities for the product suppliers operating in the space.

Gather more insights about the market drivers, restrains and growth of the Global Single-use Bioprocessing market


Furthermore, the rising number of vendors offering robust disposables for commercial manufacturing of biopharmaceuticals is one of the major factors driving the market for single-use bioprocessing. Also, the introduction of automation in the bioprocessing industry has accelerated biomanufacturing efficiency exponentially. Big data analytics is anticipated to be the major trend in the near future.

The introduction of analytical models based on big data machine-learning is anticipated to result in improvement in product yields by enabling prediction and process parameters. Currently, the adoption of disposables is relatively higher among CMOs owing to the ease of use and efficiency of SUTs in bioprocessing of multiple products requiring fast turnaround times.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

  • Large & Small-Scale Bioprocessing Market – The global large & small-scale bioprocessing (biopharmaceutical manufacturing) market size was estimated at USD 26.12 billion in 2016. Bioprocess engineering has been effectively explored for the development of biopharmaceuticals and it has provided bio manufacturers and contract manufacturing organizations (CMO) with lucrative avenues of growth.
  • Biopharmaceutical Third Party Logistics Market – The global biopharmaceutical third party logistics market size was estimated at USD 94.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2021 to 2028. The rising trend of outsourcing logistics, the focus of pharmaceutical players on their distribution network owing to its strong sales numbers, and the rise in the number of biosimilar launches are some of the key factors driving the market.

Single-use Bioprocessing Market Segmentation

Grand View Research has segmented the global single-use bioprocessing market based on product, workflow, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2017 – 2028)
    • Simple & Peripheral Elements
      • Bags
      • Tubing, Filters, Connectors, & Transfer Systems
      • Sampling Systems
      • Probes & Sensors
        • pH Sensor
        • Oxygen Sensors
        • Pressure Sensors
        • Temperature Sensors
        • Conductivity Sensors
        • Flow Sensors
        • Other sensors
      • Others
    • Apparatus & Plants
      • Bioreactors, By Capacity
        • Up to 1000L
        • Above 1000L to 2000L
        • Above 2000L
      • Filtration system
      • Mixing, Storage, & Filling Systems 
      • Chromatography Systems
      • Pumps
      • Others
    • Work Equipment
      • Cell Culture System
      • Syringes
      • Others
  • Workflow Outlook (Revenue, USD Million, 2017 – 2028)
    • Upstream
    • Fermentation
    • Downstream
  • End-use Outlook (Revenue, USD Million, 2017 – 2028)
    • Biopharmaceutical Manufacturer
      • CMOs & CROs
      • In-house Manufacturer
    • Academic & Clinical Research Institutes
  • Regional Outlook (Revenue, USD Million, 2017 – 2028)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)


Market Share Insights

  • December 2020: Thermo Fisher Scientific introduced the HyPerforma DynaDrive Single-Use Bioreactor (SUB) with improved scalability and performance. This product supports large-scale cell culture processes.
  • March 2020: GE Healthcare sold its Biopharma business to Danaher Corporation for approximately USD 20 billion in net cash. The biopharma unit is now named Cytiva.


Key Companies profiled:

Some prominent players in the global single-use bioprocessing market include

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Sartorius AG
  • Corning Incorporated
  • Pall Corporation
  • General Electric Company (GE Healthcare)
  • Eppendorf AG
  • Rentschler Biopharma SE
  • Lonza
  • Meissner Filtration Products, Inc.
  • JM BioConnect
  • Boehringer Ingelheim GmbH
  • Infors AG
  • PBS Biotech, Inc.
  • Entegris, Inc.
  • Danaher Corporation
  • Kuhner AG
  • Rentschler Biopharma SE

Order a free sample PDF of the Single-use Bioprocessing Market Intelligence Study, published by Grand View Research.

Gallium Nitride Semiconductor Devices Market is expected to expand at a CAGR of 24.4% from 2022 to 2030

Gallium Nitride Semiconductor Devices Industry Overview

The global gallium nitride semiconductor devices market size was valued at USD 1.88 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 24.4% from 2022 to 2030. The growth of the market can be attributed to the advantages offered by GaN semiconductor devices over silicon devices. Silicon materials have been used for manufacturing electronic devices such as smartphones, computers, cameras, and televisions. However, the slowdown in potential innovative properties of silicon created an opportunity for GaN semiconductor devices, which are 100 times faster than silicon. The advantages offered by GaN over silicon devices include higher energy efficiency, lower costs, and faster device speed, among others.

The growing number of electric vehicles worldwide is anticipated to drive the market. This is because GaN enables automakers to reduce vehicle charging time, improve cost efficiency, increase power density, and enhance driving range. Various companies are thereby making efforts to provide GaN systems for Electric Vehicles (EV). For instance, in November 2021, GaN Systems, a GaN power semiconductors provider, announced its partnership with Universal Scientific Industrial Co., Ltd (USI), a subsidiary of ASE Technologies. The partnership was aimed toward developing GaN power modules for the EV market.

Gather more insights about the market drivers, restrains and growth of the Global Gallium Nitride Semiconductor Devices market


Various GaN semiconductor device manufacturers receive funding from venture capital companies, which helps them to enhance their offerings and market position. For instance, in November 2021, GaN Systems, a power chip maker, announced that it raised USD 150 million in a funding round. The company used this funding to accelerate the adoption and innovation of GaN technology across its consumer, automotive, industrial, and enterprise markets. Additionally, in February 2021, Cambridge GaN Devices, a fabless semiconductor company, raised USD 9.5 million in a Series A round. The company used the funding to expand its GaN product portfolio.

The demand for GaN in 5G multi-chip modules is growing for energy-efficient mobile networks. Therefore, various semiconductor companies are making efforts to integrate GaN in 5G multi-chip modules. For instance, in June 2021, NXP Semiconductors announced the integration of GaN technology into its multi-chip module. The use of GaN in multi-chip modules increased the efficiency to higher than the company’s previous module.

The growing shipments of robots worldwide are also expected to drive the market. GaN is used for servo drives for motion control and robotics. According to the statistics provided by the International Federation of Robotics, there will be an increase in yearly robotic unit sales from 465 thousand units in 2020 to 584 thousand units in 2022. The increasing need for automation in the manufacturing process and advancements in technology are some of the factors expected to drive the sales of robot units over the forecast period.


Browse through Grand View Research’s Semiconductors Industry Research Reports.

  • Connected Cameras Market – The global connected cameras market is anticipated to witness substantial growth in coming years, on account of the rapidly rising popularity of social media imaging platforms such as Instagram, Facebook, Twitter, Google+, and Foursquare. These are cameras incorporated with built-in wireless connectivity based on several technology standards such as Wi-Fi, Near Field Communications (NFC), Bluetooth, Internet Protocol (IP), or a combination of all four.
  • Curved Televisions Market – The global curved televisions market is poised for steady growth over the forecast period owing to availability of enhanced features such as better picture quality, high contrast & less reflection, ultra high definition (UHD) resolution. In addition to these, curved television (TV) provide an enhanced viewing experience through functions such as auto depth enhancer, uniform viewing distance, and 3D & 4D compatibility.


Gallium Nitride Semiconductor Devices Market Segmentation

Grand View Research has segmented the global gallium nitride semiconductor devices market based on covid-19 impact, product, component, wafer size, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2017 – 2030)
    • GaN Radio Frequency Devices
    • Opto-semiconductors
    • Power Semiconductors
  • Component Outlook (Revenue, USD Million, 2017 – 2030)
    • Transistor
    • Diode
    • Rectifier
    • Power IC
    • Others
  • Wafer Size Outlook (Revenue, USD Million, 2017 – 2030)
    • 2-inch
    • 4-inch
    • 6-inch
    • 8-inch
  • End-use Outlook (Revenue, USD Million, 2017 – 2030)
    • Automotive
    • Consumer Electronics
    • Defense & Aerospace
    • Healthcare
    • Industrial & Power
    • Information & Communication Technology
    • Others
  • Regional Outlook (Revenue, USD Million, 2017 – 2030)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Market Share Insights

  • February 2021: Efficient Power Conversion Corporation launched EPC9157, which integrated Renesas ISL 81806 with EPC2218 eGAN to achieve more than 90% efficiency. Renesas ISL 81806 used the high performance of GaN to enable high-power solutions and reduce BOM cost, additionally making the design simple and similar to using silicon-built FETs.
  • March 2019: Cree, Inc. completed the acquisition of Advanced Technology Materials Corp., a manufacturer of GaN semiconductor devices. With this acquisition, the company extended its geographical presence in China.


Key Companies profiled:

Some prominent players in the global gallium nitride semiconductor devices market include

  • Cree, Inc.
  • Efficient Power Conversion Corporation
  • Fujitsu Ltd.
  • GaN Systems
  • Infineon Technologies AG
  • NexgenPowerSystems
  • NXP Semiconductor
  • Qorvo, Inc.
  • Texas Instruments Incorporated
  • Toshiba Corporation


Order a free sample PDF of the Gallium Nitride Semiconductor Devices Market Intelligence Study, published by Grand View Research.

Personalized Retail Nutrition And Wellness Market is expected to expand at a CAGR of 7.9% from 2021 to 2028

Personalized Retail Nutrition And Wellness Industry Overview

The global personalized retail nutrition and wellness market size was valued at USD 1.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.9% from 2021 to 2028. The market has gained significant momentum in recent years, collectively attributed to the introduction of advanced wearable solutions, expanding integration of digital technologies, and targeted scalability of direct-to-consumer e-commerce models. For instance, in November 2020, Royal DSM entered in collaboration with Huami Corp. for developing personalized nutrition solutions to address health conditions such as cardiac health, sports performance, and pre-diabetes. DSM’s AVA digital platform combined with Huami’s Amazfit wearables and PAI (Personal Activity Intelligence) helps in measuring health data in real-time. Hence, such strategies will help individuals prevent and manage lifestyle-based health conditions by leveraging new and advanced solutions.

In addition, the growing inclination towards functional foods can be further attributed to the growth of the market for personalized retail nutrition and wellness. Functional foods especially protein supplements are gradually gaining prominence and are becoming an integral part of a consumer’s daily diet. Hence, owing to the increasing demand of functional food products, companies are focusing on expanding their production for the functional food product portfolio.

Gather more insights about the market drivers, restrains and growth of the Global Personalized Retail Nutrition And Wellness Market

For instance, in February 2021, Merit Functional Foods opened a new plant-based protein manufacturing facility in Winnipeg, Manitoba. The new facility will increase the production of food-grade high purity pea and canola proteins that are used in food and beverage applications.

Moreover, the COVID-19 pandemic is acting as a positive catalyst for the growth of the market for personalized retail nutrition and wellness. People are increasingly driven to vitamin and mineral supplements for enhancing immune response. For catering to these growing needs, companies are launching new supplements. For instance, in December 2020, THE BOUNTIFUL COMPANY launched Immune 24 Hour +. It is a Non-GMO vitamin C supplement with 24-hour immune support. In addition, the soft gel of the supplement also includes Zinc and Vitamin D for added immune plus antioxidant support.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

  • Functional Foods Market – The global functional foods market size was estimated at USD 161.49 billion in 2018. It is anticipated to register a CAGR of 7.9% during the forecast period. Increasing demand for nutritional and fortifying food additives is anticipated to drive the growth. Food and beverage manufacturers are deploying fortification of nutritional additives such as omega-3 fatty acids, fibers, vitamins, minerals, and others in their product offerings.
  • Protein Supplements Market – The global protein supplements market size was valued at USD 20.47 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2021 to 2030. The market is gaining momentum owing to the increasing number of health-conscious consumers and fitness centers around the globe.

Personalized Retail Nutrition And Wellness Market Segmentation

Grand View Research has segmented the global personalized retail nutrition and wellness market based on recommendation, and region:

  • Recommendation Outlook (Revenue, USD Million, 2017 – 2028)
    • Fixed Recommendation
      • Dietary Supplements & Nutraceuticals
        • Vitamins
        • Proteins
        • Minerals
        • Amino Acids
        • Enzymes
        • Other dietary supplements & nutraceuticals
      • Functional Foods
        • Proteins
        • Vitamins
        • Dietary Fibers
        • Fatty Acids
        • Minerals
        • Prebiotics & Probiotics
        • Carotenoids
      • Traditional Botanicals
    • Repeat Recommendation
      • Dietary Supplements & Nutraceuticals
        • Vitamins
        • Proteins
        • Minerals
        • Amino Acids
        • Enzymes
        • Other dietary supplements & nutraceuticals
      • Functional Foods
        • Proteins
        • Vitamins
        • Dietary Fibers
        • Fatty Acids
        • Minerals
        • Prebiotics & Probiotics
        • Carotenoids
      • Traditional Botanicals
    • Continuous Recommendation
      • Dietary Supplements & Nutraceuticals
        • Vitamins
        • Proteins
        • Minerals
        • Amino Acids
        • Enzymes
        • Other dietary supplements & nutraceuticals
      • Functional Foods
        • Proteins
        • Vitamins
        • Dietary Fibers
        • Fatty Acids
        • Minerals
        • Prebiotics & Probiotics
        • Carotenoids
      • Traditional Botanicals
  • Regional Outlook (Revenue, USD Million, 2017 – 2028)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa (MEA)

Market Share Insights

  • October 2020: Indena has entered into a partnership with Onegevity to focus on gut microbiome testing to produce personalized nutrition pact and to focus on research and development activities for effective solutions that are synergistic to the wellness plan.
  • June 2020: Nutrigenomix launched an exclusive new line of genetic tests, an dietary assessment tool for catering to the needs of customers seeking plant-based personalized nutrition by providing DNA-based recommendations based on an individual’s genetic profile.


Key Companies profiled:

Some prominent players in the global personalized retail nutrition and wellness market include

  • Cargill, Incorporated
  • The Nature’s Bounty Co.
  • Bayer AG
  • PlateJoy
  • Better Therapeutics, Inc
  • Tracxn Technologies
  • Viome (Habit Food Personalized, LLC)
  • BitBite Inc.
  • Noom, Inc.
  • Savor Health
  • Foodsmart, Inc.
  • GLUCOVATION, INC.
  • Healbe
  • AIRO Health Care (Pty) Ltd.
  • Nutrigenomix
  • DNAfit
  • BiogeniQ Inc.
  • Vitagene
  • Consumer Physics
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Herbalife International of America, Inc.
  • Reckitt Benckiser Group PLC.
  • DowDuPont
  • Tellspec

Order a free sample PDF of the Personalized Retail Nutrition And Wellness Market Intelligence Study, published by Grand View Research.

Which are the top companies hold the market share in U.S. clinical oncology next generation sequencing market By 2024?

U.S. Clinical Oncology Next Generation Sequencing Industry Overview

Rising adoption of NGS platforms to drive demand for data analysis services during the forecast period

Widespread application of NGS due to its reliability over conventional methods for sequencing is anticipated to provide avenues for a steady increase in adoption resulting in an enhanced market penetration into the field of medical oncology over the coming years.

Rising adoption of advanced genetic sequence analysis in various fields of clinical research due to the concurrent fall in base pair mapping costs is a high impact rendering factor in favor of stable growth. A number of cancer researchers have considered the significant importance of this technology in oncology and invested efforts for the development of bioinformatics algorithms to be utilized for cancer screening and test development. A number of oncologists believe that in the coming seven years, next-generation sequencing combined with companion diagnostics can be expected to play a major role in personalized diagnostics and therapeutics and thus significant increase in demand for application of these platforms in the field can be anticipated to revolutionize the market.

Gather more insights about the market drivers, restrains and growth of the Global U.S. Clinical Oncology Next Generation Sequencing market


NGS enabled cataloging of the genomic landscape of thousands of oncogenes is anticipated to facilitate investigation of the underlying pathway behind the diseases. Furthermore, ongoing technological advancement of in silico algorithms is likely to influence the growth in market revenue. For instance, the introduction of workflow management systems solutions like Galaxy and Chipster that offer data analysis methods, are expected to further drive demand in this sector.

Strategic initiatives undertaken by the U.S. government for R&D in oncology are also projected to drive growth. Grants and loans have also been provided by the U.S government and funding bodies to narrow down the gap between genomic sequence analysis platform development and their implementation in oncology research. Furthermore, cancer-associated expenditures are anticipated to rise significantly thereby influencing the adoption of second-generation sequencing platforms for the purpose of diagnostic monitoring and theranostics applications. The most significant bottleneck in the workflow of this technology includes time-consuming interpretation of data generated in abundant amounts once the genome is sequenced, which offers innumerable opportunities for commercial service providers to develop feasible solutions with faster turnaround times.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

  • Cancer Immunotherapy Market – The global cancer immunotherapy market size was valued at USD 58.1 Billion in 2018. Growing adoption of advanced cancer therapeutic options coupled with rising cancer incidence has been one of the primary growth stimulants for the market. Healthcare providers are focusing on improving cancer therapeutic facilities and a reduction in the recurrence rate of tumor post chemotherapy.
  • Oncology Devices Market – The global oncology devices market is expected to grow during the forecast period owing to the increasing prevalence of cancer globally and the healthcare expenditure level of the patients. According to W.H.O, cancer accounted for approximately 8.2 million deaths worldwide in 2013. However, stringency in regulatory policies related to medical devices is expected to impede the growth of the market.

U.S. Clinical Oncology Next Generation Sequencing Market Segmentation

Grand View Research has segmented the global U.S. clinical oncology next generation sequencing market based on technology, workflow and end use:

  • S. Clinical Oncology NGS Outlook, by Technology (Revenue, USD Million, 2013 – 2024)
    • Targeted Sequencing & Resequencing
    • Whole Exon Sequencing
    • Whole Genome Sequencing
  • S. Clinical Oncology NGS Outlook, by Workflow (Revenue, USD Million, 2013 – 2024)
    • NGS Sequencing
    • NGS Pre-Sequencing
    • NGS Data Analysis
      • NGS Tertiary Data Analysis
      • NGS Secondary Data Analysis
      • NGS Primary Data Analysis
  • S. Clinical Oncology NGS Outlook, by End Use (Revenue, USD Million, 2013 – 2024)
    • Academic Research
    • Clinical Research
    • Hospitals & Clinics
    • Pharma & Biotech Entities
    • Other Users

Market Share Insights

  • June 2016: Thermo Fisher supported enhancement and commercialization of clinical research assay and in vitro diagnostics using NGS technology launched the Ion Torrent Developers Alliance Program.
  • February 2016: Thermo Fisher collaborated with Invivoscribe Technologies, Inc for the development of NGS based, in vitro diagnostic (IVD) oncology tests on Ion PGM Dx System which is further anticipated to accelerate the growth of the company in near future.

Key Companies profiled:

Some prominent players in the global U.S. clinical oncology next generation sequencing market include

  • Illumina Inc.
  • Roche
  • Agilent Technologies
  • Knome Inc.
  • Genomatix Software GmbH
  • GATC Biotech Ag
  • Oxford Nanopore Technologies Ltd
  • Macrogen Inc.
  • Life Technologies Corp
  • DNASTAR Inc
  • Exosome Diagnostics
  • Biomatters Ltd
  • CLC Bio
  • BGI
  • Qiagen NV
  • Perkin Elmer, Inc
  • Pacific Bioscience, Inc
  • Partek, Inc
  • GnuBIO
  • Foundation Medicine
  • Paradigm
  • Caris Life Sciences
  • Myriad Genetics.

Order a free sample PDF of the U.S. clinical oncology next generation sequencing Market Intelligence Study, published by Grand View Research.

What Are The Viral Vectors And Plasmid DNA Manufacturing Market Trends And Forecasts By 2030?

Viral Vectors And Plasmid DNA Manufacturing Industry Overview

The global viral vectors and plasmid DNA manufacturing market size was valued at USD 2.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 18.8% from 2021 to 2028. Along with the ongoing shift in the treatment paradigm of several life-threatening diseases through advanced therapies, there is rising demand for viral vector-based vaccines for infectious diseases. This has resulted in increasing employment of viral vectors and plasmid DNA for the R&D of advanced therapies, thereby driving the market for viral vectors and plasmid DNA manufacturing.

Furthermore, the COVID-19 pandemic has created lucrative opportunities for the operating players in the market. For instance, global pharmaceutical companies such as AstraZeneca, and Janssen Pharmaceuticals has developed COVID-19 viral vector-based vaccine in December 2020 and February 2021, respectively. Apart from these companies, several viral vector-based vaccines are currently in the development phase. This has accelerated the demand for viral vectors, thereby increasing revenue for viral vector manufacturers.

Gather more insights about the market drivers, restrains and growth of the Global Viral Vectors And Plasmid DNA Manufacturing Market

With the approvals of Tecartus, Zolgensma, and Kymriah, several biopharmaceutical developers have shifted their focus on this new treatment area, in turn, increasing investment flow in this market. In March 2021, the U.S. FDA approved ABECMA (idecabtagene vicleucel), a lentivirus-based gene therapy to treat R/R multiple myeloma. With the increasing gene therapy approvals and consequent increase in manufacturing capabilities, the competition in this arena is anticipated to intensify in the near future.

Moreover, market players are engaged in leveraging external capital to advance their business operations and further boost their revenue growth. Recently in April 2021, Albumedix extended research collaboration with Cobra Biologics for the upstream and downstream processing of AAV and lentiviral vector. Collaboration is intended for stability enhancement and process optimization.

Tedious and highly regulated processes for vector production and inadequate capacity for vector production are some of the key challenges in the market for viral vectors and plasmid DNA manufacturing. To overcome these challenges, more focused attempts are required. These challenges create opportunities for emerging CDMOs to capitalize on the avenues and gain considerable market share. Moreover, companies are collaborating with key operating stakeholders; including regulatory bodies, industry, and non-industry players, and others; to effectively address the challenges in viral vector production.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

  • Gene Therapy Market – The global gene therapy market size was valued at USD 2.26 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 20.4% from 2021 to 2028. The expanding arena of advanced therapies and gene delivery technologies has created an increasingly competitive dynamic where a substantial number of market players are engaged in the commercialization of their gene therapy products.
  • Advanced Therapy Medicinal Products Market – The global advanced therapy medicinal products market size was valued at USD 7.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 13.2% from 2021 to 2028. The emergence of Advanced Therapy Medicinal Products (ATMPs) has transformed the pharmaceutical industry and disease treatment landscape.


Viral Vectors And Plasmid DNA Manufacturing Market Segmentation

Grand View Research has segmented the global viral vectors and plasmid DNA manufacturing market based on vector type, workflow, application, end-use, disease, and region:

  • Vector Type Outlook (Revenue, USD Million, 2017 – 2028)
    • Adeno associated virus (AAV)
    • Lentivirus
    • Adenovirus
    • Retrovirus
    • Plasmid DNA
    • Others
  • Workflow Outlook (Revenue, USD Million, 2017 – 2028)
    • Upstream Processing
      • Vector Amplification & Expansion
      • Vector Recovery/Harvesting
    • Downstream Processing
      • Purification
      • Fill Finish
  • Application Outlook (Revenue, USD Million, 2017 – 2028)
    • Antisense & RNAi
    • Gene Therapy
    • Cell Therapy
    • Vaccinology
    • Research Applications
  • End-Use Outlook (Revenue, USD Million, 2017 – 2028)
    • Pharmaceutical and Biopharmaceutical Companies
    • Research Institutes
  • Disease Outlook (Revenue, USD Million, 2017 – 2028)
    • Cancer
    • Genetic Disorders
    • Infectious Diseases
    • Others
  • Regional Outlook (Revenue, USD Million, 2017 – 2028)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Market Share Insights

  • July 2021: the company Thermo Fisher Scientific Inc. announced the launch of new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif which will full fill the growing demand of plasmid DNA-based therapies and vital mRNA-based vaccines.
  • February 2021: Vibalogics, a Germany-based CDMO initiated the building of new virotherapy manufacturing plant in Massachusetts.


Key Companies profiled:

Some prominent players in the global viral vectors and plasmid DNA manufacturing market include

  • Merck KGaA
  • Lonza
  • FUJIFILM Diosynth Biotechnologies
  • Thermo Fisher Scientific
  • Cobra Biologics
  • Catalent Inc.
  • Wuxi Biologics
  • Takara Bio Inc.
  • Waisman Biomanufacturing
  • Genezen laboratories
  • Batavia Biosciences
  • Miltenyi Biotec GmbH
  • SIRION Biotech GmbH
  • Virovek Incorporation
  • BioNTech IMFS GmbH
  • Audentes Therapeutics
  • BioMarin Pharmaceutical
  • RegenxBio, Inc.

Order a free sample PDF of the Viral Vectors And Plasmid DNA Manufacturing Market Intelligence Study, published by Grand View Research.

Nucleic Acid Isolation And Purification Market Is Expected To Witness The Fastest Growth Rate

Nucleic Acid Isolation And Purification Industry Overview

The global nucleic acid isolation and purification market size was valued at USD 4.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2021 to 2028. Key drivers contributing to the market growth are the rise in adoption of sequencing platforms in clinical diagnostics, growth in genomics and enzymology-based research, and increasing investments in R&D pertaining to molecular biology and precision medicine.

The growing collaborations between different companies and organizations in the biotech industry is one of the factors driving the market. For instance, in March 2020, Zymo Research and Tecan partnered to introduce ready-to-use processing products that can streamline DNA or RNA extraction from COVID-19 specimens. The new DreamPrep NAP workstation assists laboratories to effectively and rapidly scale lab testing to provide a larger number of tests, consequently helping in mitigating the spread of the virus.     

The development of personalized medicine is another important factor that drives revenue generation in the market for nucleic acid isolation and purification. Next Generation Sequencing (NGS) is becoming increasingly popular in cancer tumor biopsies. Liquid biopsies are an attractive option for cancer diagnostics because the process employs a simple and routine test that can detect cancer at an early stage.


Gather more insights about the market drivers, restrains and growth of the Global Nucleic Acid Isolation And Purification market


Early diagnosis of cancer is the biggest challenge, and NGS can help effectively tackle the problem, increasing the demand for NGS technology. Therefore, an increase in the use of NGS technology is anticipated to directly impact the adoption of nucleic acid isolation and purification techniques.

Formalin-Fixed Paraffin-Embedded (FFPE) samples that are considered important in determining molecular correlates of carcinogenesis require labor-intensive nucleic acid purification for the sample, and such protocols also damage the nucleic acids. To combat such challenges companies are launching new extraction kits for efficient recovery of nucleic acids.

For instance, in March 2021, Purigen Biosystems, Inc. launched the Ionic FFPE Complete Purification Kit for recovering RNA/DNA from FFPE tissue samples in a single workflow. It helps in streamlining the workflow by reducing hands-on time by around 75% when compared to the manual column or bead-based methods. Hence, such advancements are further boosting the market growth.

Furthermore, the COVID-19 pandemic is acting as a positive catalyst for the growth of the market for nucleic acid isolation and purification. Researchers and companies across the world are focusing on developing specific assays and kits for rapid detection of SARS-CoV-2. For instance, in June 2020, Omega Bio-tek, Inc. launched Mag-Bind Viral RNA Xpress Kit for efficient and rapid isolation of viral RNA. In addition, the company also announced to have a production capacity of 6 million tests per month which brought a dramatic increase in the production capacities.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

  • Clinical Diagnostics Market – The global clinical diagnostics market is anticipated to witness growth over the forecast period, driven by the development of sophisticated and specialized tests for early disease detection and disease management and increasing demand for lab automation.
  • Genomics Market – The global genomics market size was valued at USD 20.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.35% from 2021 to 2028. The scientific community has tried to address genetic susceptibility and severity to SARS-CoV-2 infection by combining research efforts using existing genetic databases.

Nucleic Acid Isolation And Purification Market Segmentation

Grand View Research has segmented the global nucleic acid isolation and purification market based on product, type, method, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2017 – 2028)
    • Kits & Reagents
    • Instruments
  • Type Outlook (Revenue, USD Million, 2017 – 2028)
    • DNA Isolation & Purification
      • Genomic DNA Isolation & Purification
      • Plasmid DNA Isolation & Purification
      • Viral DNA Isolation & Purification
      • Other
    • RNA Isolation & Purification
      • miRNA Isolation & Purification
      • mRNA Isolation & Purification
      • Total RNA Isolation & Purification
      • Other
  • Method Outlook (Revenue, USD Million, 2017 – 2028)
    • Column-based
    • Magnetic Beads
    • Reagent-based
    • Others
  • Application Outlook (Revenue, USD Million, 2017 – 2028)
    • Precision Medicine
    • Diagnostics
    • Drug Discovery & Development
    • Agriculture and Animal Research
    • Other Applications
  • End-use Outlook (Revenue, USD Million, 2017 – 2028)
    • Academic Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations
    • Hospitals and Diagnostic Centers
    • Other End-use
  • Regional Outlook (Revenue, USD Million, 2017 – 2028)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Market Share Insights

  • June 2021: Bio-Rad Laboratories (BIO) came out with quarterly revenue of $ 3.54 per share, beating Zacks Consensus Estimate of $ 1.90 per share. That compares with $ 1.61 per share last year. These figures are adjusted for non-repetitive items.
  • January 2020: QIAGEN stated that it has completed 2,500 placements of its QIAsymphony instrument. These placements represent a great milestone for QIAGEN’s magnetic bead-based instruments.

Key Companies profiled:

Some prominent players in the global nucleic acid isolation and purification market include

  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.  
  • Danaher
  • Hoffmann-La Roche AG
  • Merck KGaA
  • Agilent Technologies
  • Bio-Rad Laboratories, Inc.
  • Takara Bio, Inc.
  • Promega Corporation
  • New England Biolabs
  • LGC Limited
  • Abcam plc
  • Norgen Biotek Corp
  • AutoGen, Inc.
  • Biogenuix
  • PCR Biosystems, Inc.
  • MagGenome
  • Apical Scientific Sdn. Bhd
  • MACHEREY-NAGEL GmbH & Co. KG

Order a free sample PDF of the nucleic acid isolation and purification Market Intelligence Study, published by Grand View Research.

Which Region Accounted For The Largest U.S. Office-based Labs Market Share By 2027?

U.S. Office-based Labs Industry Overview

The U.S. office-based labs market size was valued at USD 8.5 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.06% from 2020 to 2027. The growing trend of surgical procedures being performed in outpatient settings and the rising incidence of various vascular diseases are among the major factors driving the demand for office-based labs (OBL) in the U.S. Additionally, high patient satisfaction with a focused and dedicated team of doctors is expected to boost the market growth. Many service providers such as National Cardiovascular Partners, Envision Healthcare, and Surgery Partners are available in the country and they have been providing office-based surgical solutions and services to patients at an affordable cost.

Furthermore, key manufacturers such as Philips Healthcare and Siemens Healthineers have been entering into partnerships with physicians to set up OBLs, equipping laboratories with required devices and providing complete solutions from start to end, which is expected to propel the market growth.

Gather more insights about the market drivers, restrains and growth of the Global U.S. Office-based Labs market


When compared with hospital outpatient (HO) settings, establishing an OBL is beneficial for physicians in terms of reimbursements. There is a reduction in the cost of vascular procedures when performed in office-based laboratories due to a high reimbursement available for physicians. According to Elsevier, Inc., the percentage of procedures performed for Medicare beneficiaries increased to 76% from 2011 to 2015. Overall, the adoption of procedures has increased by 30% in HO settings, by 380% in OBLs, and has decreased by 16% in hospital inpatient (HI) settings.

The U.S. market faces challenges such as limited availability of anesthetic techniques and resources, which can put patient safety at risk, and lack of technical training for minimally invasive surgical procedures. The lack of definitive training and educational programs pertaining to the use of MIS devices makes surgeons reluctant to use this technology in OBL settings.

COVID-19 has impacted surgical procedures at hospitals and physicians’ labs. Due to the high rate of infection in the country, many surgeons have called off the service to restrict further spread. In addition, as the mode of transmission is through aerosols, anesthetists are at high risk of contracting the disease when they intubate a patient for surgery. Even though operating rooms are sterilized environments, it does not guarantee protection against infection.

Following WHO’s statements on precautions during the ongoing pandemic, the United States Surgeon General announced formal instructions to cancel elective surgeries as they may accelerate the spread of the novel coronavirus within healthcare facilities as well as consume vital medical resources required for managing COVID-19 cases. Most of the elective procedures are not an emergency. Based on a statement made by the American College of Surgeons (ACS), the Surgeon General has provided instructions to prioritize appropriate resource allocation during the novel coronavirus pandemic as it relates to elective invasive procedures. All healthcare workers are needed to take care of patients infected by the virus and the critically ill who are already hospitalized. Operating rooms have ventilators that are needed to support critically ill COVID-19 patients, which will be their priority over elective surgeries.


Browse through Grand View Research’s Medical Devices Industry Research Reports.

  • Surgical Equipment Market – The global surgical equipment market size was valued at USD 9.32 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2021 to 2028. Large unmet surgical needs, growing healthcare costs, rising geriatric population, and increasing surgical volume are the key factor projected to drive the market growth during the forecast period.
  • Infection Control Market – The global infection control market size was estimated at USD 201.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2030. The market is predominantly driven by growing number of surgical procedures that require high-intensity infection prevention.

U.S. Office-based Labs Market Segmentation

Grand View Research has segmented the global U.S. office-based labs market based on modality, specialist, and service:

  • Modality Outlook (Revenue, USD Million, 2016 – 2027)
    • Single Specialty Labs
    • Multi-specialty Labs
    • Hybrid Labs
  • Service Outlook (Revenue, USD Million, 2016 – 2027)
    • Peripheral Vascular Intervention
    • Endovascular Intervention
    • Cardiac
    • Interventional Radiology
    • Venous
    • Others
  • Specialist Outlook (Revenue, USD Million, 2016 – 2027)
    • Vascular Surgeons
    • Interventional Cardiologists
    • Interventional Radiologists
    • Others


Market Share Insights

  • December 2019: GE Healthcare launched more than 30 new smart devices and imaging intelligent applications at the Radiological Society of North America (RSNA) for radiology departments.
  • August 2019: Boston Scientific acquired BTG PLC to expand its portfolio of minimally invasive surgical devices.


Key Companies profiled:

Some prominent players in the global U.S. office-based labs market include

  • Envision Healthcare
  • Surgery Care Associates, Inc. (SCA)
  • Surgery Partners
  • National Cardiovascular Partners
  • CardioVascular Coalition
  • Tenet Healthcare Corporation

Order a free sample PDF of the U.S. office-based labs Market Intelligence Study, published by Grand View Research.

Meal Kit Delivery Services Market Worth $64.3 Billion By 2030

Meal Kit Delivery Services Industry Overview

The global meal kit delivery services market size was valued at USD 15.21 billion in 2021 and is expected to witness a compound annual growth rate (CAGR) of 17.4% from 2022 to 2030. Increasing preference for home-cooked and chef-cooked food among millennials is a major factor contributing to the growth of the market. The delivery service has been gaining high popularity and adoption among generation Y and Z.  The increasing preference for the product is driven by the benefits of homemade meals as they are more economical in comparison to takeouts and home delivery services.

The COVID-19 pandemic has offered a huge opportunity to the market for meal kit delivery services as almost all the restaurants, eateries, and hotels were shut down across the globe. People have started focusing on a healthy diet more than ever to increase their immunity and to maintain a balanced diet as a result, an increasing number of people have been looking for healthy and easy meals options. Furthermore, key players in the market have witnessed a surge in sales during the pandemic as compared to 2019. Companies like Blue Apron have also reported a hike in global sales, followed by HelloFresh, which doubled its customer base in the U.S. with an increase of 66% in its Y-O-Y revenue.

Gather more insights about the market drivers, restrains and growth of the Global Meal Kit Delivery Services market


The heat and eat segment has been gaining traction among consumers in the U.S. as several delivery service companies have been tapping into this segment by launching single and multiple servings for consumers. For instance, homemade food is more economical than eating at a restaurant. Furthermore, the availability of the product has made homemade meals more time-saving in comparison to takeouts and home delivery services. Preparing food at home also gives full control over the ingredients one wishes to use and comes in handy for people who are allergic to certain food ingredients or are trying to avoid specific ingredients.

According to a survey conducted by HUNTER in April 2020, 54% of consumers in America are cooking more than before and 22% are ordering prepared meal kits more frequently. Dining in is becoming more popular than dining out. Boomers, as well as, millennials increasingly prefer staying at home and cooking or ordering in rather than spending money at restaurants. Consumers are also making fewer visits to restaurants and are opting to stay at home. One of the key factors contributing to this shift is the attitudes and behaviors of the two largest generational groups-boomers and millennials.

While millennials have surpassed baby boomers in number, boomers remain a large population and their behaviors have a significant influence on the marketplace that caters to cooking at home. Meal kit delivery services are an ideal solution since meal planning in advance significantly helps reduce food wastage. Meal kits have ingredients in the exact quantity that is required to prepare a meal since each portion is pre-measured. Several delivery service companies offer larger portions, but still provide calorie count and nutritional information based on the portions.

Browse through Grand View Research’s Consumer F&B Industry Research Reports.

  • S. Hotels, Resorts, And Cruise Lines Market – The U.S. hotels, resorts, and cruise lines market size was valued at USD 218.50 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.3% from 2022 to 2030. The growth in the tourism and travel business in the U.S. is driving the demand. In 2020, the hotel sector had its worst year on record, with historically low occupancy, enormous job losses, and hotel closures across the country.
  • Food Dehydrators Market – The global food dehydrators market size was calculated to be USD 1.89 billion in 2018 and is anticipated to register a CAGR of 6.89% from 2019 to 2025. Factors such as increasing demand for longer shelf life of food products along with rising disposable income are expected to drive the market.

Meal Kit Delivery Services Market Segmentation

Grand View Research has segmented the global meal kit delivery services market based on offering, service, platform, meal type, and region:

  • Offering Outlook (Revenue, USD Million, 2017 – 2030)
    • Heat & Eat
    • Cook & Eat
  • Service Outlook (Revenue, USD Million, 2017 – 2030)
    • Single
    • Multiple
  • Platform Outlook (Revenue, USD Million, 2017 – 2030)
    • Online
    • Offline
  • Meal Type Outlook (Revenue, USD Million, 2017 – 2030)
    • Vegan
    • Vegetarian
    • Non-Vegetarian
  • Regional Outlook (Revenue, USD Million, 2017 – 2030)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Market Share Insights

  • August 2021: Freshly Inc., launched its first-ever plant-based prepared meals line – ‘Purely Plant’, including six new meals featuring plant-based proteins made with clean, whole-food ingredients to cater to ongoing demand for variety, taste, nutrition, plant-based meal options and convenience among consumers. Meals can be heated and served in three minutes with no preparation required.
  • November 2020: HelloFresh acquired Factor75, LLC for USD 277 million. The acquisition was aimed at strengthening HelloFresh’s position in the U.S. market and increase its consumer base across the country.

Key Companies profiled:

Some prominent players in the global meal kit delivery services market include

  • Blue Apron, LLC
  • Freshly Inc.
  • HelloFresh
  • Sun Basket
  • Relish Labs LLC (Home Chef)
  • Gobble
  • Marley Spoon Inc.
  • Purple Carrot
  • Fresh n’ Lean
  • Hungryroot

Order a free sample PDF of the Meal Kit Delivery Services Market Intelligence Study, published by Grand View Research.

Plastic Recycling Market Share and Forecast and Gross Profit Trend 2013-2028

The global Plastic Recycling market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Plastic Recycling from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Plastic Recycling market.

Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-plastic-recycling-market/request-sample

Leading players of Plastic Recycling including:
• Clear Path Recycling
• Clean Tech Incorporated
• Mohawk Industries Incorporated
• CarbonLite Industries
• Envision Plastics Industries
• Evergreen Plastics
• PolyQuest
• Phoenix Technologies
• Verdeco Recycling
• Custom Polymers
• KW plastics
• Extrupet
• Greentech
• Veolia Polymers
• Hahn Plastics
• PLASgran
• APR2 Plast
• Luxus
• Viridor
• Centriforce
• Visy
• Kyoei Industry
• Wellpine Plastic Industical
• Fuqing Topway Plastics Industrial
• Intco
• Suzhou Jiulong Recy & Tech
• Longfu Recycling Energy Scientech

Market split by Type, can be divided into:
• PET
• PP
• HDPE
• LDPE
• Others

Market split by Application, can be divided into:
• Packaging & Consumer Goods
• Construction
• Textile Fiber / Clothing
• Landscaping/Street Furniture
• Other Uses

Market split by Sales Channel, can be divided into:
• Direct Channel
• Distribution Channel

Market segment by Region/Country including:
• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Spain etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
• South America Brazil, Argentina, Colombia and Chile etc.)
• Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/2013-2028-report-on-global-plastic-recycling-market

Table of Contents

Chapter 1 Plastic Recycling Market Overview
1.1 Plastic Recycling Definition
1.2 Global Plastic Recycling Market Size Status and Outlook (2013-2028)
1.3 Global Plastic Recycling Market Size Comparison by Region (2013-2028)
1.4 Global Plastic Recycling Market Size Comparison by Type (2013-2028)
1.5 Global Plastic Recycling Market Size Comparison by Application (2013-2028)
1.6 Global Plastic Recycling Market Size Comparison by Sales Channel (2013-2028)
1.7 Plastic Recycling Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Plastic Recycling Market Segment Analysis by Player
2.1 Global Plastic Recycling Sales and Market Share by Player (2016-2018)
2.2 Global Plastic Recycling Revenue and Market Share by Player (2016-2018)
2.3 Global Plastic Recycling Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Plastic Recycling Market Segment Analysis by Type
3.1 Global Plastic Recycling Market by Type
3.1.1 PET
3.1.2 PP
3.1.3 HDPE
3.1.4 LDPE
3.1.5 Others
3.2 Global Plastic Recycling Sales and Market Share by Type (2013-2018)
3.3 Global Plastic Recycling Revenue and Market Share by Type (2013-2018)
3.4 Global Plastic Recycling Average Price by Type (2013-2018)
3.5 Leading Players of Plastic Recycling by Type in 2018
3.6 Conclusion of Segment by Type
Chapter 4 Plastic Recycling Market Segment Analysis by Application
4.1 Global Plastic Recycling Market by Application
4.1.1 Packaging & Consumer Goods
4.1.2 Construction
4.1.3 Textile Fiber / Clothing
4.1.4 Landscaping/Street Furniture
4.1.5 Other Uses
4.2 Global Plastic Recycling Sales and Market Share by Application (2013-2018)
4.3 Leading Consumers of Plastic Recycling by Application in 2018
4.4 Conclusion of Segment by Application
Chapter 5 Plastic Recycling Market Segment Analysis by Sales Channel
5.1 Global Plastic Recycling Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Plastic Recycling Sales and Market Share by Sales Channel (2013-2018)
5.3 Leading Distributors/Dealers of Plastic Recycling by Sales Channel in 2018
5.4 Conclusion of Segment by Sales Channel

Continued ………

Read all Reports of this category @ https://www.radiantinsights.com/catalog/chemicals-and-materials

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitates organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: sales@radiantinsights.com
Website: https://www.radiantinsights.com/

PLC Splitter Market Size, Share, Growth, Application and Forecast Till 2028

The global PLC Splitter market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for PLC Splitter from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the PLC Splitter market.

Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-plc-splitter-market/request-sample

Leading players of PLC Splitter including:
• NTT Electronics
• Senko
• Tianyisc
• Browave
• Corning
• Broadex
• Changzhou LINKET
• Yuda Hi-Tech
• Yilut
• Honghui
• PPI
• Korea Optron Corp
• Newfiber
• T and S Communications
• Wutong Holding Group
• Ilsintech
• Go Foton
• Sun Telecom
• Fiberon Technologies
• Korea Optron Corp

Market split by Type, can be divided into:
• Bare Type PLC Splitter
• Insertion-Type PLC Splitter
• Module PLC Splitter
• Box-Type PLC Splitter
• Tray-Type PLC Splitter
• Others

Market split by Application, can be divided into:
• PON / FTTX
• CATV
• Fiber Optic Test/Measurement
• Others

Market split by Sales Channel, can be divided into:
• Direct Channel
• Distribution Channel

Market segment by Region/Country including:
• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Spain etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
• South America Brazil, Argentina, Colombia and Chile etc.)
• Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/2013-2028-report-on-global-plc-splitter-market

Table of Contents

Chapter 1 PLC Splitter Market Overview
1.1 PLC Splitter Definition
1.2 Global PLC Splitter Market Size Status and Outlook (2013-2028)
1.3 Global PLC Splitter Market Size Comparison by Region (2013-2028)
1.4 Global PLC Splitter Market Size Comparison by Type (2013-2028)
1.5 Global PLC Splitter Market Size Comparison by Application (2013-2028)
1.6 Global PLC Splitter Market Size Comparison by Sales Channel (2013-2028)
1.7 PLC Splitter Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 PLC Splitter Market Segment Analysis by Player
2.1 Global PLC Splitter Sales and Market Share by Player (2016-2018)
2.2 Global PLC Splitter Revenue and Market Share by Player (2016-2018)
2.3 Global PLC Splitter Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 PLC Splitter Market Segment Analysis by Type
3.1 Global PLC Splitter Market by Type
3.1.1 Bare Type PLC Splitter
3.1.2 Insertion-Type PLC Splitter
3.1.3 Module PLC Splitter
3.1.4 Box-Type PLC Splitter
3.1.5 Tray-Type PLC Splitter
3.2 Global PLC Splitter Sales and Market Share by Type (2013-2018)
3.3 Global PLC Splitter Revenue and Market Share by Type (2013-2018)
3.4 Global PLC Splitter Average Price by Type (2013-2018)
3.5 Leading Players of PLC Splitter by Type in 2018
3.6 Conclusion of Segment by Type
Chapter 4 PLC Splitter Market Segment Analysis by Application
4.1 Global PLC Splitter Market by Application
4.1.1 PON / FTTX
4.1.2 CATV
4.1.3 Fiber Optic Test/Measurement
4.1.4 Others
4.2 Global PLC Splitter Sales and Market Share by Application (2013-2018)
4.3 Leading Consumers of PLC Splitter by Application in 2018
4.4 Conclusion of Segment by Application
Chapter 5 PLC Splitter Market Segment Analysis by Sales Channel
5.1 Global PLC Splitter Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global PLC Splitter Sales and Market Share by Sales Channel (2013-2018)
5.3 Leading Distributors/Dealers of PLC Splitter by Sales Channel in 2018
5.4 Conclusion of Segment by Sales Channel

Continued ………

Read all Reports of this category @ https://www.radiantinsights.com/catalog/electronics

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitates organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: sales@radiantinsights.com
Website: https://www.radiantinsights.com/

Design a site like this with WordPress.com
Get started